A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization. From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned r ...
…
continue reading
Content provided by Washington University School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Washington University School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Vaccines have arrived but COVID-19 treatments progressing much more slowly
MP3•Episode home
Manage episode 307830407 series 3010031
Content provided by Washington University School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Washington University School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy against the virus already are in use, with approval of more vaccines expected in the coming weeks. Meanwhile, the development of treatments for those infected with the virus has been slower. Only one drug, the steroid dexamethasone, has been proven to reduce the risk of death in those hospitalized with COVID-19. In this episode, we’ll hear reasons why the development of effective treatments has progressed so slowly. Discussing this with us is William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health, co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis and director of the university’s Institute of Clinical and Translational Sciences. He says one reason development of therapies has been slow is because there haven’t been enough big, well-controlled studies. We’ll also hear from Eric J. Lenze, MD, the Wallace and Lucille Renard Professor of Psychiatry, and Angela M. Reiersen, MD, an associate professor of psychiatry. They led a preliminary study at the School of Medicine in which a psychiatric drug was used to keep people with COVID-19 from getting sick enough to be hospitalized. Their study was successful. Now they’re expanding the trial to include COVID-19 patients in all of the United States.
…
continue reading
The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.
59 episodes
MP3•Episode home
Manage episode 307830407 series 3010031
Content provided by Washington University School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Washington University School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy against the virus already are in use, with approval of more vaccines expected in the coming weeks. Meanwhile, the development of treatments for those infected with the virus has been slower. Only one drug, the steroid dexamethasone, has been proven to reduce the risk of death in those hospitalized with COVID-19. In this episode, we’ll hear reasons why the development of effective treatments has progressed so slowly. Discussing this with us is William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health, co-director of the Division of Infectious Diseases at Washington University School of Medicine in St. Louis and director of the university’s Institute of Clinical and Translational Sciences. He says one reason development of therapies has been slow is because there haven’t been enough big, well-controlled studies. We’ll also hear from Eric J. Lenze, MD, the Wallace and Lucille Renard Professor of Psychiatry, and Angela M. Reiersen, MD, an associate professor of psychiatry. They led a preliminary study at the School of Medicine in which a psychiatric drug was used to keep people with COVID-19 from getting sick enough to be hospitalized. Their study was successful. Now they’re expanding the trial to include COVID-19 patients in all of the United States.
…
continue reading
The podcast, “Show Me the Science,” is produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis.
59 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.